Updated Results from the Phase 3 Manifest-2 Study of Pelabresib in Combination with Ruxolitinib for Janus Kinase Inhibitor-Naive Patients with Myelofibrosis John O. Mascarenhas , Sebastian Grosicki , Dominik Chraniuk , Elisabetta Abruzzese , Prithviraj Bose , Aaron T. Gerds , Alessandro M. Vannucchi , Francesca Palandri , Sung-Eun Lee , Vikas Gupta , Alessandro Lucchesi , Stephen Oh , Andrew T. Kuykendall , Andrea Patriarca , Alberto Alvarez-Larran , Ruben Mesa , Jean-Jacques Kiladjian , Moshe Talpaz , Morgan Harris , Sarah-Katharina Kays , Qing Li , Barbara Brown , Anna-Maria Jegg , Claire Harrison , Raajit Rampal BLOOD（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
